Insider · CIK 0001465278

Hagan Joseph P

CIK 0001465278 Name as filed on the most recent filing

Filed as Hagan Joseph P (29)

36 transaction lines · from 29 filings · filed 2012-06-29 to 2025-01-31 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

36 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2025-01-30 P, Open-market purchase Regulus Therapeutics Inc.RGLS 54,260, acquired Open Form 4 filing 0000950170-25-011853
2025-01-14 S, Open-market sale Regulus Therapeutics Inc.RGLS 14,860, disposed Open Form 4 filing 0000950170-25-005883
2025-01-13 S, Open-market sale Regulus Therapeutics Inc.RGLS 145,634, disposed Open Form 4 filing 0000950170-25-005883
2024-01-18 S, Open-market sale Regulus Therapeutics Inc.RGLS 17,359, disposed Open Form 4 filing 0001209191-24-001873
2023-05-19 S, Open-market sale Aurinia Pharmaceuticals Inc.AUPH 2,878, disposed Open Form 4 filing 0001600620-23-000021
2022-01-26 P, Open-market purchase Regulus Therapeutics Inc.RGLS 21,520, acquired Open Form 4 filing 0001209191-22-005061
2022-01-03 S, Open-market sale Aurinia Pharmaceuticals Inc.AUPH 2 lines 903,650, disposed Open Form 4 filing 0001628280-22-000182
2021-05-17 S, Open-market sale Regulus Therapeutics Inc.RGLS 3,726, disposed Open Form 4 filing 0001209191-21-033297
2021-02-16 S, Open-market sale Regulus Therapeutics Inc.RGLS 7,128, disposed Open Form 4 filing 0001209191-21-026951
2021-02-16 S, Open-market sale Regulus Therapeutics Inc.RGLS 7,128, disposed Open Form 4 filing 0001209191-21-011377
2020-11-16 S, Open-market sale Regulus Therapeutics Inc.RGLS 3,176, disposed Open Form 4 filing 0001209191-20-059050
2020-08-14 S, Open-market sale Regulus Therapeutics Inc.RGLS 2,568, disposed Open Form 4 filing 0001209191-20-047033
2020-05-15 S, Open-market sale Regulus Therapeutics Inc.RGLS 2,774, disposed Open Form 4 filing 0001209191-20-030089
2020-02-18 S, Open-market sale Regulus Therapeutics Inc.RGLS 3,591, disposed Open Form 4 filing 0001209191-20-010754
2020-01-02 S, Open-market sale Regulus Therapeutics Inc.RGLS 8,067, disposed Open Form 4 filing 0001209191-20-000785
2019-11-14 S, Open-market sale Regulus Therapeutics Inc.RGLS 3,736, disposed Open Form 4 filing 0001209191-19-056799
2019-10-01 S, Open-market sale Regulus Therapeutics Inc.RGLS 5,969, disposed Open Form 4 filing 0001209191-19-051910
2019-08-15 S, Open-market sale Regulus Therapeutics Inc.RGLS 2,409, disposed Open Form 4 filing 0001209191-19-046314
2019-07-01 S, Open-market sale Regulus Therapeutics Inc.RGLS 7,584, disposed Open Form 4 filing 0001209191-19-040504
2019-05-16 S, Open-market sale Regulus Therapeutics Inc.RGLS 47,966, disposed Open Form 4 filing 0001209191-19-030512
2019-05-07 P, Open-market purchase Regulus Therapeutics Inc.RGLS 35,850, acquired Open Form 4 filing 0001209191-19-028281
2019-04-01 S, Open-market sale Regulus Therapeutics Inc.RGLS 5,731, disposed Open Form 4 filing 0001209191-19-023136
2017-07-25 P, Open-market purchase Regulus Therapeutics Inc.RGLS 200,000, acquired Open Form 4 filing 0001209191-17-046233
2016-03-03 P, Open-market purchase Regulus Therapeutics Inc.RGLS 71,900, acquired Open Form 4 filing 0001209191-16-106685
2014-09-15 P, Open-market purchase Orexigen Therapeutics, Inc.OREX 23,450, acquired Open Form 4 filing 0001181431-14-031926
2013-07-31 S, Open-market sale Orexigen Therapeutics, Inc.OREX 93,600, disposed Open Form 4 filing 0001181431-13-042654
2013-07-26 S, Open-market sale Orexigen Therapeutics, Inc.OREX 74,000, disposed Open Form 4 filing 0001181431-13-041738
2013-05-28 S, Open-market sale Orexigen Therapeutics, Inc.OREX 196,000, disposed Open Form 4 filing 0001181431-13-031630
2012-07-13 S, Open-market sale Orexigen Therapeutics, Inc.OREX 2 lines 203,000, disposed Open Form 4 filing 0001181431-12-040672
2012-06-29 S, Open-market sale Orexigen Therapeutics, Inc.OREX 75,600, disposed Open Form 4 filing 0001181431-12-038584
2012-06-28 S, Open-market sale Orexigen Therapeutics, Inc.OREX 153,400, disposed Open Form 4 filing 0001181431-12-038584
2012-06-27 S, Open-market sale Orexigen Therapeutics, Inc.OREX 3 lines 368,000, disposed Open Form 4 filing 0001181431-12-038584

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director
O, Officer
Officer

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 6
  • Open-market sale 30
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Hagan Joseph P, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001465278

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.